Viewing Study NCT00179751


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2026-03-28 @ 9:59 AM
Study NCT ID: NCT00179751
Status: TERMINATED
Last Update Posted: 2005-11-07
First Post: 2005-09-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas
Sponsor: Celgene Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cc-5013 View
None revlimid View
None pancreatic cancer View